Skip to main content
OpenTrials
Completed

NCT Number: NCT02019862

TRJ Post Market Clinical Follow Up

Clinical and radiological 2 years results of TRJ® Hip Stem.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Total Hip Arthroplasty

Sex eligibility

All sexes

Study type

Observational

Primary location

Dreifaltigkeitskrankenhaus Köln

Cologne, 50933, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion:

  • TRJ® implantation performed
  • patient consent available for participation in the study

Exclusion:

  • permanent cortisone therapy
  • alcohol or drug abuse

Treatment and study plan

TRJ® Total Hip Arthroplasty

Device

Primary outcomes

  1. Implant Survival

    Time frame: 24 months

Secondary outcomes

  1. Clinical Outcome

    Time frame: 24 months

    Harris Hip Score

  2. Osteolysis

    Time frame: 24 months

    Radiological Outcome

  3. Ossification

    Time frame: 24 months

    Radiological Outcome

  4. Migration

    Time frame: 24 months

    Radiological Outcome

  5. TRJ® Implant Position

    Time frame: 24 months

    Radiological Outcome

Sponsors and collaborators

Lead sponsor

Aesculap AG

Industry

Registry information

Official study title

TRJ PMCF Köln: 2-years Results

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Dec 24, 2013
Registry last updated
Apr 16, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.